Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Deonarain

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|November 1, 1994
Targeting enzymes for cancer therapy: old enzymes in new rolesM P Deonarain, A A Epenetos
British Journal of Cancer|March 4, 1998
Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxinsM P Deonarain, A A Epenetos
Cell Biophysics|January 1, 1994
Targeting phosphodiesterases as a strategy for killing tumor cellsM P Deonarain, A A Epenetos
Biotechnology Letters|February 5, 2010
Modulating the pharmacokinetics of therapeutic antibodiesA Constantinou, C Chen, M P Deonarain
International Journal of Cancer|May 8, 2000
A recombinant cytotoxic chimera based on mammalian deoxyribonuclease-IH Linardou, A A Epenetos, M P Deonarain
Gene Therapy|May 1, 1995
DNA vaccination for cancer treatmentR A Spooner, M P Deonarain, A A Epenetos
Biochemistry|February 11, 1992
Engineering surface charge. 2. A method for purifying heterodimers of Escherichia coli glutathione reductaseM P Deonarain, N S Scrutton, R N Perham
Gene Therapy|June 1, 1995
Genetic delivery of enzymes for cancer therapyM P Deonarain, R A Spooner, A A Epenetos
Biochemistry|February 11, 1992
Engineering surface charge. 1. A method for detecting subunit exchange in Escherichia coli glutathione reductaseM P Deonarain, N S Scrutton, R N Perham
Cell Biophysics|January 1, 1993
A universal antibody-derived targeting agentR A Spooner, M P Deonarain, P Savage, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|November 1, 1994
Targeting enzymes for cancer therapy: old enzymes in new rolesM P Deonarain, A A Epenetos
British Journal of Cancer|March 4, 1998
Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxinsM P Deonarain, A A Epenetos
Cell Biophysics|January 1, 1994
Targeting phosphodiesterases as a strategy for killing tumor cellsM P Deonarain, A A Epenetos
Biotechnology Letters|February 5, 2010
Modulating the pharmacokinetics of therapeutic antibodiesA Constantinou, C Chen, M P Deonarain
International Journal of Cancer|May 8, 2000
A recombinant cytotoxic chimera based on mammalian deoxyribonuclease-IH Linardou, A A Epenetos, M P Deonarain
Gene Therapy|May 1, 1995
DNA vaccination for cancer treatmentR A Spooner, M P Deonarain, A A Epenetos
Biochemistry|February 11, 1992
Engineering surface charge. 2. A method for purifying heterodimers of Escherichia coli glutathione reductaseM P Deonarain, N S Scrutton, R N Perham
Gene Therapy|June 1, 1995
Genetic delivery of enzymes for cancer therapyM P Deonarain, R A Spooner, A A Epenetos
Biochemistry|February 11, 1992
Engineering surface charge. 1. A method for detecting subunit exchange in Escherichia coli glutathione reductaseM P Deonarain, N S Scrutton, R N Perham
Cell Biophysics|January 1, 1993
A universal antibody-derived targeting agentR A Spooner, M P Deonarain, P Savage, et al.
Pageof 3